Table 2.
Newly diagnosed HIV cases, n % | Univariate analysis | Multivariable analysis (n = 10,257) | ||||||
---|---|---|---|---|---|---|---|---|
Factor | total with DSS/DPS4 | with recent infection | OR* | 95% CI° | OR* | 95% CI° | ||
Total | 10,257 | 100% | 3,084 | 30.01% | ||||
Gender | ||||||||
Men | 8,541 | 83.3% | 2,705 | 31.7% | (ref) | (ref) | ||
Women | 1,716 | 16.7% | 379 | 22.1% | 0.61# | 0.54–0.69 | 0.94 | 0.79–1.12 |
Region of origin | ||||||||
Germany | 6,405 | 62.5% | 2,121 | 33.1% | (ref) | (ref) | ||
Abroad | 2,853 | 27.8% | 673 | 23.6% | 0.62# | 0.56–0.69 | 0.74# | 0.66–0.84 |
Unknown | 999 | 9.7% | 290 | 29.0% | 0.83## | 0.71–0.96 | 0.94 | 0.80–1.11 |
Age group | ||||||||
< 25 years | 1,216 | 11.9% | 523 | 43.0% | (ref) | (ref) | ||
25–34 years | 3,443 | 33.6% | 1,091 | 31.7% | 0.61# | 0.54–0.70 | 0.63# | 0.55–0.72 |
35–44 years | 2,986 | 29.1% | 846 | 28.3% | 0.52# | 0.46–0.60 | 0.53# | 0.46–0.61 |
45–54 years | 1,838 | 17.9% | 470 | 25.6% | 0.46# | 0.39–0.53 | 0.45# | 0.39–0.53 |
> =55 years | 774 | 7.5% | 154 | 19.9% | 0.33# | 0.27–0.41 | 0.35# | 0.28–0.43 |
Mode of transmission | ||||||||
MSM1 | 5,993 | 58.4 | 2,095 | 35.0% | (ref) | (ref) | ||
HET2 | 1,909 | 18.6 | 393 | 20.6% | 0.48# | 0.43–0.55 | 0.65# | 0.54–0.79 |
IDU3 | 307 | 3.0 | 107 | 34.9% | 1.00 | 0.78–1.27 | 1.18 | 0.92–1.51 |
Unknown | 2,048 | 20.0 | 489 | 23.9% | 0.58# | 0.52–0.65 | 0.68# | 0.60–0.77 |
Region of presumed infection | ||||||||
Germany | 7,124 | 69.4% | 2,346 | 32.9% | (ref) | (ref) | ||
Abroad | 1,803 | 17.6% | 387 | 21.5% | 0.56# | 0.49–0.63 | 0.85## | 0.73–0.99 |
Unknown | 1,330 | 13.0 | 351 | 26.4% | 0.73# | 0.64–0.83 | 0.98 | 0.84–1.14 |
1MSM: men who have sex with men
2IDU: persons who are intravenous drug users
3HET: persons with heterosexual contact
4 DSS/DPS: Dried Serum Spot/Dried Plasma Spot
*OR: odds ratio
°95% CI: 95% Confidence interval
# p-value: p < =0.001
## p-value: p < =0.05